Evidence also supports the formation of “inflammatory TLOs” under T1D setting, since administration of LTbetaR-Ig neutralizes the function of LTs, disassembles the established TLO and prevents T1D development at both early and late stage (47). Here, LTBR is linked to type 1 diabetes mellitus.